Loading clinical trials...

Transcranial Direct Current Stimulation (tDCS) and Intensive Therapy in Aphasia | Clinical Trials | Clareo Health

COMPLETEDNANCT03510182

Transcranial Direct Current Stimulation (tDCS) and Intensive Therapy in Aphasia

Intensive therapy for aphasia has been demonstrated to improve language functioning after stroke or other neurological injury. However, recovery is generally not complete and new therapies are needed ...

Lead sponsor: University of Michigan•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Related studies

RECRUITINGPhase 2

Balancing Effortful and Errorless Learning in Naming Treatment for Aphasia

NCT05653440 · Aphasia, Stroke

RECRUITING

Speech and Language Interventions for Italian People With PPA

NCT06739967 · Primary Progressive Aphasia(PPA)

RECRUITING

UPenn Observational Research Repository on Neurodegenerative Disease

NCT04715399 · Frontotemporal Degeneration(FTD), Primary Progressive Aphasia(PPA), and more

RECRUITINGNA

Cognitive Reserve and Response to Speech-Language Intervention in Bilingual Speakers With Primary Progressive Aphasia

NCT05741853 · Primary Progressive Aphasia, Dementia, and more

RECRUITINGNA

Neuroplasticity Biomarkers in Aphasia

NCT06471127 · Aphasia, Language, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: September 20, 2021Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment25

Start dateDec 2016

Last updatedSep 20, 2021

Condition

Aphasia

Locations shown

University Center for Language and Literacy

Ann Arbor, Michigan

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 20, 2021Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions